222 related articles for article (PubMed ID: 31754123)
1. Partial reduced Pi transport function of PiT-2 might not be sufficient to induce brain calcification of idiopathic basal ganglia calcification.
Nishii K; Shimogawa R; Kurita H; Inden M; Kobayashi M; Toyoshima I; Taguchi Y; Ueda A; Tamune H; Hozumi I
Sci Rep; 2019 Nov; 9(1):17288. PubMed ID: 31754123
[TBL] [Abstract][Full Text] [Related]
2. Novel SLC20A2 mutations identified in southern Chinese patients with idiopathic basal ganglia calcification.
Chen WJ; Yao XP; Zhang QJ; Ni W; He J; Li HF; Liu XY; Zhao GX; Murong SX; Wang N; Wu ZY
Gene; 2013 Oct; 529(1):159-62. PubMed ID: 23939468
[TBL] [Abstract][Full Text] [Related]
3. Inorganic phosphorus (Pi) in CSF is a biomarker for SLC20A2-associated idiopathic basal ganglia calcification (IBGC1).
Hozumi I; Kurita H; Ozawa K; Furuta N; Inden M; Sekine SI; Yamada M; Hayashi Y; Kimura A; Inuzuka T; Seishima M
J Neurol Sci; 2018 May; 388():150-154. PubMed ID: 29627011
[TBL] [Abstract][Full Text] [Related]
4. Familial idiopathic basal ganglia calcification: Histopathologic features of an autopsied patient with an SLC20A2 mutation.
Kimura T; Miura T; Aoki K; Saito S; Hondo H; Konno T; Uchiyama A; Ikeuchi T; Takahashi H; Kakita A
Neuropathology; 2016 Aug; 36(4):365-71. PubMed ID: 26635128
[TBL] [Abstract][Full Text] [Related]
5. SLC20A2 variants cause dysfunctional phosphate transport activity in endothelial cells induced from Idiopathic Basal Ganglia Calcification patients-derived iPSCs.
Sekine SI; Nishii K; Masaka T; Kurita H; Inden M; Hozumi I
Biochem Biophys Res Commun; 2019 Mar; 510(2):303-308. PubMed ID: 30704756
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and therapeutic potential of sodium-dependent phosphate cotransporters in relation to idiopathic basal ganglia calcification.
Inden M; Kurita H; Hozumi I
J Pharmacol Sci; 2022 Jan; 148(1):152-155. PubMed ID: 34924120
[TBL] [Abstract][Full Text] [Related]
7. Role of phosphate transporter PiT-2 in the pathogenesis of primary brain calcification.
Inden M; Kimura Y; Nishii K; Masaka T; Takase N; Tsutsui M; Ohuchi K; Kurita H; Hozumi I
Biochem Biophys Res Commun; 2023 Jan; 640():21-25. PubMed ID: 36495606
[TBL] [Abstract][Full Text] [Related]
8. Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification.
Hsu SC; Sears RL; Lemos RR; Quintáns B; Huang A; Spiteri E; Nevarez L; Mamah C; Zatz M; Pierce KD; Fullerton JM; Adair JC; Berner JE; Bower M; Brodaty H; Carmona O; Dobricić V; Fogel BL; García-Estevez D; Goldman J; Goudreau JL; Hopfer S; Janković M; Jaumà S; Jen JC; Kirdlarp S; Klepper J; Kostić V; Lang AE; Linglart A; Maisenbacher MK; Manyam BV; Mazzoni P; Miedzybrodzka Z; Mitarnun W; Mitchell PB; Mueller J; Novaković I; Paucar M; Paulson H; Simpson SA; Svenningsson P; Tuite P; Vitek J; Wetchaphanphesat S; Williams C; Yang M; Schofield PR; de Oliveira JR; Sobrido MJ; Geschwind DH; Coppola G
Neurogenetics; 2013 Feb; 14(1):11-22. PubMed ID: 23334463
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells derived from a patient with familial idiopathic basal ganglia calcification (IBGC) caused by a mutation in SLC20A2 gene.
Sekine SI; Kondo T; Murakami N; Imamura K; Enami T; Shibukawa R; Tsukita K; Funayama M; Inden M; Kurita H; Hozumi I; Inoue H
Stem Cell Res; 2017 Oct; 24():40-43. PubMed ID: 29034894
[TBL] [Abstract][Full Text] [Related]
10. Fahr's disease linked to a novel SLC20A2 gene mutation manifesting with dynamic aphasia.
Brighina L; Saracchi E; Ferri F; Gagliardi M; Tarantino P; Morzenti S; Musarra M; Patassini M; Annesi G; Ferrarese C
Neurodegener Dis; 2014; 14(3):133-8. PubMed ID: 25348593
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features of familial idiopathic basal ganglia calcification caused by a novel mutation in the SLC20A2 gene].
Zhu M; Fang C; Li X; Zhou M; Wan H; Hong D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Feb; 32(1):64-8. PubMed ID: 25636102
[TBL] [Abstract][Full Text] [Related]
12. SLC20A2-Associated Idiopathic basal ganglia calcification (Fahr disease): a case family report.
Li M; Fu Q; Xiang L; Zheng Y; Ping W; Cao Y
BMC Neurol; 2022 Nov; 22(1):438. PubMed ID: 36397039
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of SLC20A2 mutations that cause idiopathic basal ganglia calcification in Japan.
Yamada M; Tanaka M; Takagi M; Kobayashi S; Taguchi Y; Takashima S; Tanaka K; Touge T; Hatsuta H; Murayama S; Hayashi Y; Kaneko M; Ishiura H; Mitsui J; Atsuta N; Sobue G; Shimozawa N; Inuzuka T; Tsuji S; Hozumi I
Neurology; 2014 Feb; 82(8):705-12. PubMed ID: 24463626
[TBL] [Abstract][Full Text] [Related]
14. A Novel
Ding Y; Dong HQ
Chin Med J (Engl); 2018 Apr; 131(7):799-803. PubMed ID: 29578123
[TBL] [Abstract][Full Text] [Related]
15. Analysis of gene expression pattern and neuroanatomical correlates for SLC20A2 (PiT-2) shows a molecular network with potential impact in idiopathic basal ganglia calcification ("Fahr's disease").
da Silva RJ; Pereira IC; Oliveira JR
J Mol Neurosci; 2013 Jun; 50(2):280-3. PubMed ID: 23576097
[TBL] [Abstract][Full Text] [Related]
16. SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia.
Baker M; Strongosky AJ; Sanchez-Contreras MY; Yang S; Ferguson W; Calne DB; Calne S; Stoessl AJ; Allanson JE; Broderick DF; Hutton ML; Dickson DW; Ross OA; Wszolek ZK; Rademakers R
Neurogenetics; 2014 Mar; 15(1):23-30. PubMed ID: 24135862
[TBL] [Abstract][Full Text] [Related]
17. [Progress on the Pathophysiology of Idiopathic Basal Ganglia Calcification].
Hozumi I
Brain Nerve; 2019 Jan; 71(1):59-66. PubMed ID: 30630130
[TBL] [Abstract][Full Text] [Related]
18. Familial idiopathic basal ganglia calcification with a heterozygous missense variant (c.902C>T/p.P307L) in SLC20A2 showing widespread cerebrovascular lesions.
Sakai K; Ishida C; Hayashi K; Tsuji N; Kannon T; Hosomichi K; Takei N; Kakita A; Tajima A; Yamada M
Neuropathology; 2022 Apr; 42(2):126-133. PubMed ID: 35026865
[TBL] [Abstract][Full Text] [Related]
19. Association between a novel mutation in SLC20A2 and familial idiopathic basal ganglia calcification.
Zhang Y; Guo X; Wu A
PLoS One; 2013; 8(2):e57060. PubMed ID: 23437308
[TBL] [Abstract][Full Text] [Related]
20. The type III transporters (PiT-1 and PiT-2) are the major sodium-dependent phosphate transporters in the mice and human brains.
Inden M; Iriyama M; Zennami M; Sekine SI; Hara A; Yamada M; Hozumi I
Brain Res; 2016 Apr; 1637():128-136. PubMed ID: 26923164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]